10 September 2025 | Sheraton Towers Singapore

In conjunction with

Asia Pacific Biologics CDMO Excellence Award 2025 aims to celebrate the outstanding contributions of leading Contract Development and Manufacturing Organisations (CDMOs) that are accelerating biologics innovation across Asia Pacific. This prestigious award recognises excellence in biomanufacturing, cutting-edge R&D, technological innovation, and strategic partnerships that drive the development and commercialisation of novel biologic therapies.

Honouring pioneers, visionaries and trailblazers in the biologics outsourcing space—from early-stage process development to large-scale commercial manufacturing—the APAC Biologics CDMO Excellence Award applauds those setting new industry benchmarks and raising the standard of biomanufacturing in the region.

The Awards Ceremony will take place in conjunction with the 4th Annual Biologics CDMO Asia 2025, on 10th September 2025, in Singapore.

Timeline of Asia Pacific Biologics CDMO Excellence Award 2025

Why our awards?

The Asia Pacific Biologics CDMO Excellence Award 2025 celebrates the outstanding contributions of leading Contract Development and Manufacturing Organisations (CDMOs) accelerating biologics innovation across the region. This prestigious award recognises excellence in biomanufacturing, cutting-edge R&D, technological breakthroughs, and strategic partnerships that shape the future of biologic therapies.

Honouring pioneers, visionaries and trailblazers in the biologics outsourcing landscape, the award applauds those setting new industry benchmarks — from early-stage process development to large-scale commercial manufacturing.

The Awards Ceremony will take place at the 4th Annual Biologics CDMO Asia 2025, on 10th September 2025, in Singapore.

AWARD WINNERS

AWARD NOMINEES

Bioprocessing Technology Excellence Award Categories

2025 Categories	Nominee 1	Nominee 2	Nominee 3	Nominee 4	Nominee 5	Nominee 6
Best Biologics CDMO Award: Bioprocessing	ProBio, China	WuXi Biologics, China	Samsung Biologics, S.Korea	Celltrion, S.Korea	Syngene International, India
Best Biologics CDMO Award: Scale-Up	ProBio, China	Mycenax, Taiwan	Bora Biologics, Taiwan	BioCina, Australia	Chime Biologics, China
Best Biologics CDMO Award: Automation	Samsung Biologics, S.Korea	3SBio, China	Porton, China	WuXi XDC, China	Lotte Biologics, S.Korea
Best Biologics CDMO Award: Fill-Finish	Amaran Biotech, Taiwan	BioCina, Australia	ST Pharm, S.Korea	Hanmi Pharmaceutical, S.Korea	Prestige Biologics, S.Korea	Boehringer Ingelheim BioXcellence, China
Best Biologics CDMO Award: Analytical Services	Syngene International, India	Novartis Contract Manufacturing, Singapore	FUJIFILM Biotechnologies, Japan	Aragen Life Sciences, India	Bora Biologics, Taiwan	Bora Pharmaceutical, Taiwan
Best Biologics CDMO Award: Quality	ProBio, China	OneSource, India	Lonza, Singapore	WuXi XDC China	Thousand Oaks Biopharmaceuticals, China

Biologics CDMO Regional & Leadership Excellence Award Categories

2025 Categories	Nominee 1	Nominee 2	Nominee 3	Nominee 4	Nominee 5	Nominee 6	Nominee 7
Best Biologics CDMO in South-East Asia	Biocon Biologics, Malaysia	BioNet-Asia, Thailand	Esco Aster, Singapore	Daewoong Infion, Indonesia	Genepeutic Bio, Thailand
Best Biologics CDMO in Greater China Region	ProBio, China	Canton Biologics Co., Ltd., China	TOT Biopharma, China	WuXi Biologics, China	Chime Biologics, China	Zencore Biologics, China
Best Biologics CDMO in Japan	AGC Biologics, Japan	Bushu Pharma, Japan	MEDINET, Japan	Takara Bio, Japan	Ajinomoto Bio-Pharma Services
Best Biologics CDMO in South Asia	Aragen Life Sciences, India	Piramal Pharma Solutions, India	Enzene Biosciences, India	Stelis Biopharma, India	Kemwell Biopharma, India	Syngene International, India	Aurigene Pharmaceutical Services, India
Best Biologics CDMO in South Korea	STgen Bio, S.Korea	SK Bioscience, S.Korea	LOTTE Biologics, S.Korea	Hanmi Pharma, S.Korea	GC Biopharma, S.Korea	Prestige Biologics, S.Korea
Best Biologics CDMO in Australasia	BioCina, Australia	IDT, Australia	BioSouth, New Zealand	Cell Therapies, Australia	Thermo Fisher Scientifc (Patheon), Australia
Best Emerging CDMO of the Year	STgen Bio, S.Korea	Aurigene Pharmaceutical Services, India	Laurus Bio, India	Locus Cell, Taiwan	BiBo Pharma, China
CDMO of the Year – Asia Pacific	STgen Bio, S.Korea	VectorBuilder, Australia	ProBio, China	Canton Biologics Co., Ltd., China	Lotte Biologics, S.Korea	WuXi Biologics, China	Samsung Biologics, S.Korea
Best Cell Therapy CDMO – Asia Pacific	ProBio, China	BioCina, Australia	Novartis Contract Manufacturing, Singapore	WuXi Apptec, China	AGC Biologics, Japan	FUJIFILM Biotechnologies, Japan	Thermo Fisher Scientific (Patheon), Australia
Best Gene Therapy CDMO – Asia Pacific	ProBio, China	Takara Bio, Japan	TFBS Bioscience, Taiwan	WuXi Apptec, China	FUJIFILM Biotechnologies, Japan	VectorBuilder, Australia
Best mRNA CDMO – Asia Pacific	ProBio, China	SK Bioscience, S.Korea	Elixirgen Scientific, Japan	Samsung Biologics, S.Korea	GC Biopharma, S.Korea	Takara Bio, Japan

Charmaine Poh

Business Development Manager

[email protected]

+65 6983 6133

Ana Laxamana

Business Development Manager

[email protected]

+65 69836132

Nathan Grace Niño

Business Development Manager

[email protected]

+65 69836134 | +44 161 552 8521

Reserve your seat today for Asia Pacific Biologics CDMO Excellence Award 2025!

► REGISTER NOW ◄

VISIT OUR WEBSITE